KRATOM LEGALITY AND KRATOM CONSUMER PROTECTION ACT

The industrial revolution enabled faster and more efficient production. Our pharmaceutical industry, for example, is very good at isolating 1 active ingredient, then chemically synthesizing a similar molecule on a massive scale. This is analogous to our food supply in the US…which is optimized for mass-production and scalability…and not necessarily for our ‘best’ long term health.

It is understandable that the FDA turned away from biologics back in the 1970s in order to enable this scalability. The FDA has a tough job of regulating labels, claims, and manufacturing practices before trying to consider the complexities of biologic therapeutics. However, the more our collective knowledge increases, we begin to understand the importance of these biologic complexities and the symbiotic relationships present within our microbiomes called the human body. More than ever, it is important for new disruptive industries to come together to promote education and commit to acceptable standards.

As this shift from synthetics to biologics and natural products gains momentum, it is critical to meet with our legislators. In order to reduce risks and provide maximum societal benefits as kratom gains in awareness and popularity.